Invesco Ltd. - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,048,469
-14.3%
134,938
+6.7%
0.00%
Q2 2023$1,223,813
-11.9%
126,427
-0.2%
0.00%
Q1 2023$1,388,752
+289.3%
126,711
+53.4%
0.00%
Q4 2022$356,758
-46.4%
82,583
-6.6%
0.00%
Q3 2022$665,000
-23.4%
88,451
+2.3%
0.00%
Q2 2022$868,000
+114.3%
86,466
+164.0%
0.00%
Q1 2022$405,000
+55.2%
32,751
+187.0%
0.00%
Q4 2021$261,000
-19.4%
11,411
-22.0%
0.00%
Q3 2021$324,000
+39.1%
14,629
-18.6%
0.00%
Q2 2021$233,000
+385.4%
17,971
+69.9%
0.00%
Q4 2017$48,00010,5780.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 503,248$6,535,00010.30%
Prosight Management, LP 360,834$4,685,0003.84%
Healthcare Value Capital, LLC 100,000$1,299,0002.89%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,748,208$22,700,0002.32%
DG Capital Management, LLC 591,154$7,676,0001.83%
NEA Management Company, LLC 5,172,683$67,193,0001.51%
Altium Capital Management LP 408,908$5,310,0001.47%
IRONWOOD INVESTMENT MANAGEMENT LLC 170,316$2,212,0001.17%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 298,500$3,875,0001.02%
KNOTT DAVID M 154,840$2,011,0000.86%
View complete list of AURINIA PHARMACEUTICALS INC shareholders